A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2.
Saved in:
| Title: | A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2. |
|---|---|
| Authors: | Tsegay KB; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States., Adeyemi CM; St. Louis University School of Medicine, Department of Pharmacology and Physiology, St. Louis, MO, United States., Gniffke EP; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States., Sather DN; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States.; Department of Pediatrics, University of Washington, Seattle, WA, United States., Walker JK; St. Louis University School of Medicine, Department of Pharmacology and Physiology, St. Louis, MO, United States.; Henry and Amelia Nasrallah Center for Neuroscience, Saint Louis University St. Louis, Seattle, WA, United States., Smith SEP; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, United States.; Department of Pediatrics, University of Washington, Seattle, WA, United States.; Graduate Program in Neuroscience, University of Washington, Seattle, WA, United States. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2021 Jun 14; Vol. 12, pp. 685308. Date of Electronic Publication: 2021 Jun 14 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
